| 1 |
Iron metabolism and management: focus on chronic kidney disease |
|
|
| Anil K. Agarwal |
|
| Kidney International Supplements. 2021; 11(1): 46 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 2 |
Effect of hepcidin antagonists on anemia during inflammatory disorders |
|
|
| Poonam Sagar, Stanzin Angmo, Rajat Sandhir, Vikas Rishi, Hariom Yadav, Nitin Kumar Singhal |
|
| Pharmacology & Therapeutics. 2021; 226: 107877 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 3 |
Neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in evaluation of inflammation in non-dialysis patients with end-stage renal disease (ESRD) |
|
|
| Peiyuan Li, Chenqi Xia, Peng Liu, Zhong Peng, Hong Huang, Juan Wu, Zhangxiu He |
|
| BMC Nephrology. 2020; 21(1) |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 4 |
The Influence of Inflammation on Anemia in CKD Patients |
|
|
| Anna Gluba-Brzózka, Beata Franczyk, Robert Olszewski, Jacek Rysz |
|
| International Journal of Molecular Sciences. 2020; 21(3): 725 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 5 |
Resistin hormone in diabetic kidney disease and its relation to iron status and hepcidin |
|
|
| Zhian Sherzad Hayder, Zrar Saleem Kareem |
|
| International Urology and Nephrology. 2020; 52(4): 749 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 6 |
Study of hepcidin level in patients with chronic kidney disease and its correlation with markers of iron status in Zagazig University Hospital |
|
|
| Nafesa M. Kamal, Magda Diab, Rania A. Khalil |
|
| The Egyptian Journal of Internal Medicine. 2018; 30(4): 284 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 7 |
Iron status in patients with chronic heart failure |
|
|
| E. A. Jankowska,J. Malyszko,H. Ardehali,E. Koc-Zorawska,W. Banasiak,S. von Haehling,I. C. Macdougall,G. Weiss,J. J. V. McMurray,S. D. Anker,M. Gheorghiade,P. Ponikowski |
|
| European Heart Journal. 2013; 34(11): 827 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 8 |
Noninvasive assessment of bone health in Indian patients with chronic kidney disease |
|
|
| Jabbar, Z. and Aggarwal, P.K. and Chandel, N. and Khandelwal, N. and Kohli, H.S. and Sakhuja, V. and Jha, V. |
|
| Indian Journal of Nephrology. 2013; 23(3): 161-167 |
|
| [Pubmed] [Google Scholar] |
|
| 9 |
Acute and sub-acute effect of ferric carboxymaltose on inflammation and adhesion molecules in patients with predialysis chronic renal failure [Efecto agudo y subagudo de la carboximaltosa férrica sobre la inflamación y moléculas de adhesión en pacientes con insuficiencia renal crónica prediálisis] |
|
|
| Prats, M. and Font, R. and GarcÃa-Ruiz, C. and Cabré, C. and Muñoz-Cortés, M. and Rosa Nogués, M. and Jariod, M. and Romeu, M. and MartÃnez-Vea, A. |
|
| Nefrologia. 2013; 33(3): 355-361 |
|
| [Pubmed] [Google Scholar] |
|
| 10 |
Hepcidin and iron metabolism disorders in patients with chronic kidney disease [Hepcidin i poremecaji metabolizma gvožda kod bolesnika sa hronicnom bubrežnom bolešcu] |
|
|
| Jelic, M. and Cvetkovic, T. and Djordjevic, V. and Damnjanovic, G. and Vlahovic, P. and Kocic, G. and Djindjic, N. and Jovovic, B. and Antic, A. |
|
| Vojnosanitetski Pregled. 2013; 70(4): 368-373 |
|
| [Pubmed] [Google Scholar] |
|
| 11 |
Iron status in patients with chronic heart failure |
|
|
| Jankowska, E.A. and Malyszko, J. and Ardehali, H. and Koc-Zorawska, E. and Banasiak, W. and Von Haehling, S. and MacDougall, I.C. and Weiss, G. and McMurray, J.J.V. and Anker, S.D. and Gheorghiade, M. and Ponikowski, P. |
|
| European Heart Journal. 2013; 34(11): 827-834 |
|
| [Pubmed] [Google Scholar] |
|
| 12 |
Cytotoxic CD4+CD28null T lymphocytes, systemic inflammation and atherosclerotic risk in patients with chronic kidney disease |
|
|
| Yadav, A.K. and Lal, A. and Jha, V. |
|
| Nephron - Clinical Practice. 2012; 120(4): c185-c193 |
|
| [Pubmed] [Google Scholar] |
|
| 13 |
Association between serum neopterin and inflammatory activation in chronic kidney disease |
|
|
| Yadav, A.K. and Sharma, V. and Jha, V. |
|
| Mediators of Inflammation. 2012; 2012(476979) |
|
| [Pubmed] [Google Scholar] |
|
| 14 |
Association between Serum Neopterin and Inflammatory Activation in Chronic Kidney Disease |
|
|
| Ashok Kumar Yadav,Vinod Sharma,Vivekanand Jha |
|
| Mediators of Inflammation. 2012; 2012: 1 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 15 |
Cytotoxic CD4+CD28null T Lymphocytes, Systemic Inflammation and Atherosclerotic Risk in Patients with Chronic Kidney Disease |
|
|
| Ashok Kumar Yadav,Anupam Lal,Vivekanand Jha |
|
| Nephron Clinical Practice. 2012; 120(4): c185 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 16 |
CD4+CD28null cells are expanded and exhibit a cytolytic profile in end-stage renal disease patients on peritoneal dialysis |
|
|
| A. K. Yadav,V. Jha |
|
| Nephrology Dialysis Transplantation. 2011; 26(5): 1689 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 17 |
Association of circulating fractalkine (CX3CL1) and CX3CR1 +CD4 + T cells with common carotid artery intima-media thickness in patients with chronic kidney disease |
|
|
| Yadav, A.K., Lal, A., Jha, V. |
|
| Journal of Atherosclerosis and Thrombosis. 2011; 18(11): 958-965 |
|
| [Pubmed] [Google Scholar] |
|
| 18 |
CD4+CD28null cells are expanded and exhibit a cytolytic profile in end-stage renal disease patients on peritoneal dialysis |
|
|
| Yadav, A.K., Jha, V. |
|
| Nephrology Dialysis Transplantation. 2011; 26(5): 1689-1694 |
|
| [Pubmed] [Google Scholar] |
|
| 19 |
Iron status in ESRD patients |
|
|
| Wiwanitkit, V. |
|
| Indian Journal of Nephrology. 2011; 21(1): 67-68 |
|
| [Pubmed] [Google Scholar] |
|
|
Editorial Board
